Clinical Trial Update: A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a Phase 1/2 study of ANS02 in participants with EGFR mutation-positive non-small cell lung cancer, currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ANS02

Snippet

Sponsor: Avistone Biotechnology Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING